Circumvent

About:

Circumvent is a biotech company

Website: https://www.circumventpharmaceuticals.com/

Top Investors: Y Combinator, DAYLI Financial Group, Heritage Provider Network, The Longevity Fund

Description:

Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, the Longevity Fund, and additional investors.

Total Funding Amount:

$7.93M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Portland, Oregon, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)circumventpharmaceuticals.com

Founders:

Andrew Lim, Devin Wiley, Samy Hamdouche

Number of Employees:

1-10

Last Funding Date:

2021-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai